コンテンツへスキップ
Merck
  • Fatty acid biosynthesis is involved in the production of hepatitis B virus particles.

Fatty acid biosynthesis is involved in the production of hepatitis B virus particles.

Biochemical and biophysical research communications (2016-05-15)
Hitomi Okamura, Yasunori Nio, Yuichi Akahori, Sulyi Kim, Koichi Watashi, Takaji Wakita, Makoto Hijikata
要旨

Hepatitis B virus (HBV) proliferates in hepatocytes after infection, but the host factors that contribute to the HBV lifecycle are poorly understood at the molecular level. We investigated whether fatty acid biosynthesis (FABS), which was recently reported to contribute to the genomic replication of hepatitis C virus, plays a role in HBV proliferation. We examined the effects of inhibitors of the enzymes in the FABS pathway on the HBV lifecycle by using recombinant HBV-producing cultured cells and found that the extracellular HBV DNA level, reflecting HBV particle production, was decreased by treatment with inhibitors suppressed the synthesis of long-chain saturated fatty acids with little cytotoxicity. The reduced HBV DNA level was reversed when palmitic acid, which is the product of fatty acid synthase (FAS) during FABS, was used simultaneously with the inhibitor. We also observed that the amount of intracellular HBV DNA in the cells was increased by FAS inhibitor treatment, suggesting that FABS is associated with HBV particle production but not its genome replication. This suggests that FABS might be a potent target for anti-HBV drug with a mode of action different from current HBV therapy.

材料
製品番号
ブランド
製品内容

Sigma-Aldrich
CP-640186 hydrochloride, ≥95% (HPLC)